Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study / 대한소아소화기영양학회지
Pediatric Gastroenterology, Hepatology & Nutrition
; : 35-48, 2020.
Article
em En
| WPRIM
| ID: wpr-782186
Biblioteca responsável:
WPRO
ABSTRACT
6 years (RR=4.15), with previous abdominal pain (RR=7.2) or constipation (RR=4.06). Constipation was recorded in 23/289 (8.0%), with increased risk in children having surgery (RR=2.56) or previous constipation (RR=7.38). Probiotic supplementation significantly reduced AAD (RR=0.30) and abdominal pain (RR=0.36). Lactobacillus rhamnosus GG (LGG) and L. reuteri significantly reduced AAD (RR=0.37 and 0.35) and abdominal pain (RR=0.37 and 0.24).CONCLUSION: AAD occurred in 20.4% of children, with increased risk at younger age, lower respiratory and urinary tract infections, intravenous treatment and previous AAD. LGG and L. reuteri reduced both AAD and associated abdominal pain.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Infecções Urinárias
/
Dor Abdominal
/
Incidência
/
Estudos Prospectivos
/
Constipação Intestinal
/
Probióticos
/
Diarreia
/
Limosilactobacillus reuteri
/
Lacticaseibacillus rhamnosus
/
Administração Intravenosa
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Child
/
Humans
Idioma:
En
Revista:
Pediatric Gastroenterology, Hepatology & Nutrition
Ano de publicação:
2020
Tipo de documento:
Article